Please use this identifier to cite or link to this item:
Title: Quality audit of the guidelines for the use of RhD immunoglobulin in obstetrics: Are we getting it right?
Authors: Glazebrook, Bridget
Akers, Christine
Bielby, Linley
Bastin, Kaylene
Von Wielligh, Kobie
Daly, James
Citation: © 2020 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Aust N Z J Obstet Gynaecol. 2020 Aug;60(4):504-508. doi: 10.1111/ajo.13177. Epub 2020 May 18.
Abstract: BACKGROUND: Administration of RhD immunoglobulin (Ig) is important for RhD negative women throughout pregnancy and postnatally to prevent alloimmunisation and haemolytic disease of the fetus and newborn in subsequent pregnancies. AIMS: The aim of this audit was to understand compliance with the Australian guidelines on RhD Ig prophylaxis in pregnancy. MATERIALS AND METHODS: This was a retrospective audit of RhD negative pregnant women in Victoria, Northern Territory, Australian Capital Territory and Tasmania at maternity services of level 2 or higher care, between July 2017 and June 2018. Medical records were reviewed to identify how many RhD negative women received care compliant with the guidelines covering antibody testing, consent, administration of RhD Ig, and feto-maternal haemorrhage (FMH) quantification. RESULTS AND CONCLUSIONS: Analysis included 939 RhD negative women from 43 health services. Compliance with postnatal RhD Ig was high (98%); however, other practice was poor. Documented consent was obtained and recorded for 585 women (62%). Only 76% of eligible women received RhD Ig at the appropriate dose and time (28 and 34 weeks gestation). Similarly, management of potentially sensitising events was suboptimal with 78% receiving RhD Ig when recommended by guidelines. The results of our audit indicate a need for practice improvement across all aspects of care for women who need to receive RhD Ig. A major focus should be not just educating clinical staff, but also educating women to understand the importance of RhD Ig and the potential impact on subsequent pregnancies in order to improve guideline adherence and reduce risk.
Click to open Pubmed Article:
Journal title: The Australian & New Zealand journal of obstetrics & gynaecology
Volume: 60
Pages: 504-508
Publication Date: 2020-08
Type: Journal Article
DOI: 10.1111/ajo.13177
Orcid: 0000-0002-4880-7036
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.

Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing


PubMed References

Who's citing